Page 139 - Read Online
P. 139

Ibrahim et al                                                                                                                                                                                        ALDHs and prostate cancer

               stem cells. Clin Transl Med 2013;2:3.             Mitochondrial pyruvate carrier function determines cell stemness and
           210. Rodriguez-Torres M, Allan AL. Aldehyde dehydrogenase as a marker   metabolic reprogramming in cancer cells. Oncotarget 2017;8:46363-80.
               and functional mediator of metastasis in solid tumors. Clin Exp   222. Clark DW, Palle K. Aldehyde dehydrogenases in cancer stem cells:
               Metastasis 2016;33:97-113.                        potential as therapeutic targets. Ann Transl Med 2016;4:518.
           211.  Januchowski R, Wojtowicz K, Zabel M. The role of aldehyde   223. Castro Nava A, Cojoc M, Peitzsch C, Cirillo G, Kurth I, Fuessel
               dehydrogenase (ALDH) in cancer drug resistance.  Biomed   S, Erdmann K, Kunhardt D, Vittorio O, Hampel S, Dubrovska A.
               Pharmacother 2013;67:669-80.                      Development of novel radiochemotherapy approaches targeting
           212. Di C, Zhao Y. Multiple drug resistance due to resistance to stem cells   prostate tumor progenitor cells using nanohybrids. Int J Cancer
               and stem cell treatment progress in cancer (Review). Exp Ther Med   2015;137:2492-503.
               2015;9:289-93.                                 224. Maitland NJ. Getting closer to prostate cancer in patients - what
           213. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen   scientists should want from clinicians. J Cancer Metastasis Treat
               DT, Tai LK, Yung MC, Chang SC, Ku HH, Chiou SH, Lo WL.   2017;3:262-70.
               Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells   225. Chen Y, Koppaka V, Thompson DC, Vasiliou V. Focus on molecules:
               in head and neck squamous cancer. Biochem Biophys Res Commun   ALDH1A1: from lens and corneal crystallin to stem cell marker. Exp
               2009;385:307-13.                                  Eye Res 2012;102:105-6.
           214. Vinogradov S, Wei X. Cancer stem cells and drug resistance: the   226. Vasiliou V, Pappa A, Petersen DR. Role of aldehyde dehydrogenases
               potential of nanomedicine. Nanomedicine (Lond) 2012;7:597-615.  in endogenous and xenobiotic metabolism. Chem Biol Interact
           215. Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat   2000;129:1-19.
               Rev Cancer 2002;2:38-47.                       227. Stagos D, Chen Y, Brocker C, Donald E, Jackson BC, Orlicky DJ,
           216. McKenna DJ, Errington R, Pors K. Current challenges and   Thompson DC, Vasiliou V. Aldehyde dehydrogenase 1B1: molecular
               opportunities in treating hypoxic prostate tumors. J Cancer   cloning and characterization of a novel mitochondrial acetaldehyde-
               Metastasis Treat 2018;4:11.                       metabolizing enzyme. Drug Metab Dispos 2010;38:1679-87.
           217. Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg   228. Krupenko SA. FDH: an aldehyde dehydrogenase fusion enzyme in
               RE, Hanlon AL, Iyer R, Hanks GE. Hypoxic regions exist in human   folate metabolism. Chem Biol Interact 2009;178:84-93.
               prostate carcinoma. Urology 1999;53:11-8.      229.  Krupenko NI, Dubard ME, Strickland KC, Moxley KM, Oleinik
           218. Stewart GD, Ross JA, McLaren DB, Parker CC, Habib FK, Riddick   NV, Krupenko SA. ALDH1L2 is the mitochondrial homolog
               ACP. The relevance of a hypoxic tumour microenvironment in   of 10-formyltetrahydrofolate dehydrogenase.  J Biol Chem
               prostate cancer. BJU International 2010;105:8-13.  2010;285:23054-61.
           219. Cojoc M, Peitzsch C, Kurth I, Trautmann F, Kunz-Schughart LA,   230. Matsumoto A. Fundamental properties of aldehyde dehydrogenase 2
               Telegeev GD, Stakhovsky EA, Walker JR, Simin K, Lyle S, Fuessel   (ALDH2) and the importance of the ALDH2 polymorphism. Nihon
               S, Erdmann K, Wirth MP, Krause M, Baumann M, Dubrovska A.   Eiseigaku Zasshi 2016;71:55-68. (in Japanese)
               Aldehyde dehydrogenase is regulated by beta-catenin/TCF and   231. Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA. Aldehyde
               promotes radioresistance in prostate cancer progenitor cells. Cancer   dehydrogenases and cell proliferation. Free Radic Biol Med
               Res 2015;75:1482-94.                              2012;52:735-46.
           220. Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, Luthra S,   232. Holmes RS. Biochemical genetics of opossum aldehyde
               Chandran UR, Benos PV, Smith L, Wang M, Hu B, Cheng SY, Sobol   dehydrogenase 3: evidence for three ALDH3A-like genes and an
               RW, Nakano I. Mesenchymal glioma stem cells are maintained by   ALDH3B-like gene. Biochem Genet 2010;48:287-303.
               activated glycolytic metabolism involving aldehyde dehydrogenase   233. Kim KJ, Pearl PL, Jensen K, Snead OC, Malaspina P, Jakobs C,
               1A3. Proc Natl Acad Sci U S A 2013;110:8644-9.    Gibson KM. Succinic semialdehyde dehydrogenase: biochemical-
           221. Li X, Han G, Li X, Kan Q, Fan Z, Li Y, Ji Y, Zhao J, Zhang M,   molecular-clinical disease mechanisms, redox regulation, and
               Grigalavicius M, Berge V, Goscinski MA, Nesland JM, Suo Z.   functional significance. Antioxid Redox Signal 2011;15:691-718.



























                           Journal of Cancer Metastasis and Treatment ¦ Volume 4 ¦ Aug 21, 2018            17
   134   135   136   137   138   139   140   141   142   143   144